Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis

por Aapro, M, Coiffier, B, Dunst, J, Österborg, A, Burger, H U
Publicado 2006

Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

por Karlsson, C, Dahl, H, Lundin, J, Rossmann, E, Brytting, M, Mellstedt, H, Linde, A, Österborg, A
Publicado 2011

Targets for Ibrutinib Beyond B Cell Malignancies

por Berglöf, A., Hamasy, A., Meinke, S., Palma, M., Krstic, A., Månsson, R., Kimby, E., Österborg, A., Smith, C. I. E.
Publicado 2015

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

por Ludwig, Heinz, Aapro, M., Bokemeyer, C., Glaspy, J., Hedenus, M., Littlewood, T.J., Österborg, A., Rzychon, B., Mitchell, D., Beguin, Y.
Publicado 2014

Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia

por Olsson, A, Norberg, M, ökvist, A, Derkow, K, Choudhury, A, Tobin, G, Celsing, F, österborg, A, Rosenquist, R, Jondal, M, Osorio, L M
Publicado 2007

NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy

por Mozaffari, F, Lindemalm, C, Choudhury, A, Granstam-Björneklett, H, Helander, I, Lekander, M, Mikaelsson, E, Nilsson, B, Ojutkangas, M-L, Österborg, A, Bergkvist, L, Mellstedt, H
Publicado 2007

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

por Hojjat-Farsangi, M., Daneshmanesh, A. H., Khan, A. S., Shetye, J., Mozaffari, F., Kharaziha, P., Rathje, L.-S., Kokhaei, P., Hansson, L., Vågberg, J., Byström, S., Olsson, E., Löfberg, C., Norström, C., Schultz, J., Norin, M., Olin, T., Österborg, A., Mellstedt, H., Moshfegh, A.
Publicado 2018